[mct Co., Ltd.] mct Event | 3rd special event for pharmaceutical companies 4 insights to connect “patients, doctors, and the
pharmaceutical industry” Image
URL: mct Co., Ltd. Press release: November 7, 2024 mct Event | 3rd special event for pharmaceutical companies 4 insights to connect “patients, doctors, and the pharmaceutical industry” ―A collection of voices from doctors and patients that opens up new possibilities in healthcare―
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-7f4e9d235b748919f308bac6fa24503d-850×442.png
decision-making on treatment matters between patients and doctors). Now that medical care has become mainstream, we believe that there is a need for a “reset” to appropriately handle the “voices” of patients, patients’ families, doctors, and others. This time, as the third special event for pharmaceutical companies, the mct medical design platform will hold an event focusing on how to utilize the voices of patients, patient families, and doctors. As speakers, 8 people from 6 companies continue to influence the future of healthcare by coming into close contact with the “voices” of patients and their families through their daily activities and using them to create new services and businesses. professionals gather together. We will introduce our unique “Torisetsu” over 4 days. Please join us at this event and take home clues for connecting patients, patient families, doctors, and the pharmaceutical industry. Program introduction *Program content and speakers are subject to change due to circumstances. INSIGHT 1 “Efforts to reflect the voices of patients and their families will accelerate What is patient-centered drug discovery and clinical trials? ” ────────────────────────────────────────── 11/21 (Thursday) 18:00 – 19:00 Online seminar [Free] Speaker: Mr. Shingo Hayashi (Representative Director of Beta Trip Co., Ltd.) ⇒Developing various businesses in the area of mental illness, centered on a community site for families of patients with depression ( https://encourages.jp/ ) Mr. Takuro Miyazaki (Representative Director, Gutte Co., Ltd.) ⇒ Management of “G Community”, an online community for IBD patients and patient families ( https://gcarecommunity.com/ ) In “INSIGHT 1,” the first event of this event, we will introduce two initiatives to incorporate the voices of patients and their families, with the aim of realizing patient-centered drug discovery and clinical trials. ■Promoting participation and building trust in psychiatric clinical trials: Challenges and possibilities of introducing DCT from the perspective of patients and families BetaTrip Co., Ltd., which operates a variety of businesses in the field of mental illness, conducted a survey to explore challenges and possibilities from the perspective of patients and patients’ families regarding clinical trials and the introduction of DCT (distributed clinical trials) in the field of mental illness. ｡We would like to tell you about our efforts to increase patient awareness of clinical trials and encourage their participation. ■About “indirect roundtable discussions” to reflect patient voices in drug discovery and clinical research Gutte Co., Ltd., which operates “G Community,” is working with researchers involved in drug discovery and clinical development at Shonan iPark to carry out initiatives to reflect patient voices in drug development. I would like to talk about an “indirect roundtable discussion” held between researchers and volunteer IBD (inflammatory bowel disease) patients.
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-df5a0fd348f2d01f9d085ea6eac18c08-950×906.png Mr. Shingo Hayashi (Representative Director of Beta Trip Co., Ltd.)
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-ac6d4e138eec36ad951bde499a42343c-1006×894.png Mr. Takuro Miyazaki (Representative Director of Gutte Co., Ltd.) Apply for the INSIGHT1. seminar INSIGHT 2 “Solving communication issues based on the voices of patients with incurable diseases and their families How was the solution created? ” ────────────────────────────────────────── 11/25 (Monday) 18:00 – 19:00 Online Seminar [Free] Speaker: Mr. Yasuomi Hayashi
(Representative Director, Knock on the Door Co., Ltd.) Mr. Takashi Nukaya (Executive Officer, Knock on the Door Co., Ltd.) ⇒Provide business development and business support centered on support platforms for patients and families ( https://knockonthedoor.jp/ ) “INSIGHT 2” introduces communication issues with patients and their families and the efforts that have been made to solve them. ■About PHR solution development that utilizes patient feedback collected through the app Knock on the Door Co., Ltd., which operates the app
“nanacara,” uses the app to listen to the voices of patients with incurable diseases and their families, and to identify issues together with companies. By forming a team to solve this problem and building a solution, we have grown “nanacara” to become the most used PHR solution in the epilepsy field. We would like to tell you about our efforts to resolve these communication issues with patients and their families.
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-51661bdf2c7f492576f57a3f5df0ab5d-946×856.png Mr. Yasuomi Hayashi (Representative Director of Knock on the Door Co., Ltd.)
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-a81c9cfdd8af83264d75c9bd960bec31-910×874.png Mr. Takashi Nukaya (Executive Officer of Knock on the Door Co., Ltd.) Apply for the INSIGHT2. seminar INSIGHT 3 “By using big data analysis to unravel tens of thousands of voices from apps and communities What is the ideal form of patient care? ” ────────────────────────────────────────── 11/27 (Wed) 18:00 – 19:00 Online seminar [Free] Speaker: Mr. Ryotaro Ako (Representative of Atopiyo LLC) ⇒ Development and operation of “Atopiyo” app for atopic dermatitis patients, big data analysis, disease awareness support ( https://www.atopiyo.com/ ) Ms. Nobuko Ueda (Representative Director of Lisa Sarna Co., Ltd.) Misato Tsukuda (Director and CSO of Lisa Sarna Co., Ltd.) ⇒Operation of female cancer patient community SNS “Peering” and “Peering Blue” ( https://risa-sana.co.jp/ ) In “INSIGHT 3,” we will introduce two initiatives to utilize the vast amount of patient feedback, not only in treatment, but also in total patient care, through big data analysis and other techniques. ■Patient insights and disease awareness – Exploring patient communities and big data – Atopiyo LLC, which operates the app “Atopiyo” for atopic dermatitis patients, has visualized the timing of switching to new drugs and changes in symptoms based on 60,000 images and 50,000 reviews posted on the app. We are collaborating with university hospitals and facilities to advance big data analysis using AI image analysis and natural language analysis. This app also functions as a disease awareness platform. I would like to talk about the various initiatives we have implemented to improve patient care. ■Connecting patient insights derived from Japan’s largest cancer community to total care There are currently more than 18,000 users of Peering and Peering Blue, community-type SNS for cancer survivors operated by Lisa Sarna Co., Ltd. For these users, we conducted various qualitative and quantitative surveys such as a survey on side effects, as well as analysis to explore changes in patients’ emotions and networking trends from over 1 million posted data. We will tell you about our efforts to connect all stakeholders to realize patient-centered medical care and total care.
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-4da3f3fbaff0aea626e0a0712f850634-930×870.png Mr. Ryotaro Ako (Representative of Atopiyo LLC)
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-e7f933350e34c4e7f1dbbfd5577c611e-908×858.png Ms. Nobuko Ueda (Representative Director of Lisa Sarna Co., Ltd.)
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-9ba24f1dcc4bd09af7b02a85a130f7d1-932×866.png Misato Tsukuda (Director CSO of Lisa Sarna Co., Ltd.) Apply for the INSIGHT3. seminar INSIGHT 4 “ By looking at the patient journey quantitatively, we can see What is the communication gap between patients and doctors? ”
────────────────────────────────────────── 11/28 (Thursday) 16:30 – 18:30 Real event [Paid] [Recruitment capacity] Venue 30 people *There is no online viewing [Venue] Daishinsha Co., Ltd. Tokyo Office: Daiwa Jingumae Building 1F, 2-4-11 Jingumae, Shibuya-ku, Tokyo
[Participation fee] 1,500 yen (tax included) *Please pay at the reception on the day (we will give you a receipt) *Networking is planned after the event (18:30-19:30) Refreshments will be provided during the networking session. Main speaker: Mr. Takeshi Taguchi (Representative of PM Link LLC) ⇒Marketing research support in the healthcare field, and data collection and visualization tools Development ( https://www.pmlink.jp/ ) Norihiko Yoshioka (MCT Medical Design Platform Co., Ltd.) Koji Hodino (mct Medical Design Platform Co., Ltd.) ( https://mctinc.jp/ ) As an original project for this event, we will be holding a report on the results of an independent survey jointly conducted by PM Link LLC and MCT as a real event. ■We conducted patient surveys in various disease areas (atopic dermatitis, epilepsy, IBD, depression, female cancer, etc.) using “Life Log” (a tool that allows you to easily create a journey online) developed by PM Link LLC. By using this tool to quantitatively capture the patient journey, which is usually analyzed qualitatively, we derive new insights that were previously invisible. *Survey panel cooperation: Asmark Co., Ltd. ■At the same time, we conducted an awareness survey among doctors regarding “patient information they really want to know.” While comparing the results of quantitative analysis of the patient journey, we will also report on the communication gap between patients and doctors. *Survey panel cooperation: Macromil Care Net Co., Ltd. ―――――――――――――――――――――――――――――――――――――――――― ★In addition, on the day of the event, we are planning a simple work session using “Life Log” for those who participate. This is a great opportunity to experience “Life Log”, so please join us. ★In addition, on the day of the event, speakers from the online seminar will be invited to participate in “INSIGHT 1-3” for a panel discussion on what is important for connecting patients, doctors, and the pharmaceutical industry. There will also be a question and answer session on the spot, so please join us. *Details will be announced later to those who will participate.
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-d0672fa92364a740298c324283801193-920×874.png Mr. Takeshi Taguchi (Representative of PM Link LLC)
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-28ce41c8b35d6b010593f5fbb02f43cd-912×864.png Norihiko Yoshioka (mct Medical Design Platform Co., Ltd.)
https://prcdn.freetls.fastly.net/release_image/40643/31/40643-31-ac21a3043f8ccd5850b20b64926eab42-914×864.png Koji Hodino (mct Medical Design Platform Co., Ltd.) Apply for the INSIGHT4. seminar
